mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.5 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.5 |